818
Views
9
CrossRef citations to date
0
Altmetric
Author's View

Fbxw7 suppresses cancer metastasis by inhibiting niche formation

&
Article: e1022308 | Received 17 Feb 2015, Accepted 17 Feb 2015, Published online: 30 Jun 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Erika Vacchelli, Norma Bloy, Fernando Aranda, Aitziber Buqué, Isabelle Cremer, Sandra Demaria, Alexander Eggermont, Silvia Chiara Formenti, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2016) Trial Watch: Immunotherapy plus radiation therapy for oncological indications. OncoImmunology 5:9.
Read now

Articles from other publishers (8)

Zhuang Chen, Qiming Wang, Jinbo Liu, Wenkang Wang, Weitang Yuan, Yang Liu, Zhenqiang Sun & Chengzeng Wang. (2024) Effects of extracellular vesicle-derived noncoding RNAs on pre-metastatic niche and tumor progression. Genes & Diseases 11:1, pages 176-188.
Crossref
Siyu Chen, Ping Leng, Jinlin Guo & Hao Zhou. (2023) FBXW7 in breast cancer: mechanism of action and therapeutic potential. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Meghdad Eslami, Saba Khazeni, Xaniar Mohammadi Khanaghah, Mohammad Hossein Asadi, Mohamad Amin Ansari, Javad Hayati Garjan, Mohammad Hassan Lotfalizadeh, Mobina Bayat, Mohammad Taghizadieh, Seyed Pouya Taghavi, Michael R Hamblin & Javid Sadri Nahand. (2023) MiRNA-related metastasis in oral cancer: moving and shaking. Cancer Cell International 23:1.
Crossref
Xiuzhen Zhang, Tong Meng, Shuaishuai Cui, Dongwu Liu, Qiuxiang Pang & Ping Wang. (2022) Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (Review). International Journal of Oncology 61:1.
Crossref
Debdeep Dutta, Vartika Sharma, Mousumi Mutsuddi & Ashim Mukherjee. (2021) Regulation of Notch signaling by E3 ubiquitin ligases. The FEBS Journal 289:4, pages 937-954.
Crossref
Takaaki Masuda, Miwa Noda, Takahiro Kogawa, Dai Kitagawa, Naoki Hayashi, Takahito Jomori, Yoichi Nakanishi, Keiichi I. Nakayama, Shinji Ohno & Koshi Mimori. (2020) Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer. Cancer Science 111:3, pages 924-931.
Crossref
Bethsebie Lalduhsaki Sailo, Kishore Banik, Sosmitha Girisa, Devivasha Bordoloi, Lu Fan, Clarissa Esmeralda Halim, Hong Wang, Alan Prem Kumar, Dali Zheng, Xinliang Mao, Gautam Sethi & Ajaikumar Bahulayan Kunnumakkara. (2019) FBXW7 in Cancer: What Has Been Unraveled Thus Far?. Cancers 11:2, pages 246.
Crossref
Yangke Cai, Meng Zhang, Xiaofu Qiu, Bingwei Wang, Yu Fu, Jun Zeng, Jian Bai & Guosheng Yang. (2017) Upregulation of FBXW7 Suppresses Renal Cancer Metastasis and Epithelial Mesenchymal Transition. Disease Markers 2017, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.